NCT03056339 2024-03-25Umbilical & Cord Blood (CB) Derived CAR-Engineered NK Cells for B Lymphoid MalignanciesM.D. Anderson Cancer CenterPhase 1/2 Completed49 enrolled 12 charts
NCT03807063 2020-08-14Rivogenlecleucel Donor Lymphocyte Immunotherapy in Treating Patients With Recurrent Blood Cancers After Stem Cell TransplantFred Hutchinson Cancer CenterPhase 1 Withdrawn